Cytochrome P450 2B6 Inhibitors [MoA] - N0000182139

Pharmacologic Class Information

Pharmacologic Code N0000182139
Pharmacologic Name Cytochrome P450 2B6 Inhibitors
Pharmacologic Uses
  • anthelmintic
  • cortisol synthesis inhibitor
  • kinase inhibitor
  • nitroimidazole antimicrobial
  • selective norepeinephrine reuptake inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Cytochrome P450 2B6 Inhibitors

The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Cytochrome P450 2B6 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-4512Fexinidazole Non-Proprietary Name: FexinidazoleTabletOralSanofi-aventis U.s. LlcACTIVE
0069-8140Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8141Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0078-0937Egaten Non-Proprietary Name: TriclabendazoleTabletOralNovartis Pharmaceuticals CorporationACTIVE
17772-131Qelbree Non-Proprietary Name: Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncACTIVE
17772-132Qelbree Non-Proprietary Name: Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncACTIVE
17772-133Qelbree Non-Proprietary Name: Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncACTIVE
70127-100Epidiolex Non-Proprietary Name: CannabidiolSolutionOralGreenwich Biosciences, LlcACTIVE
72065-003Recorlev Non-Proprietary Name: LevoketoconazoleTabletOralXeris Pharmaceuticals, Inc.ACTIVE